BCL2 and liver disorder: PI3K/Akt activation can heighten the levels of the downstream antiapoptotic protein Bcl2, promoting the activation of caspase 3, decreasing the expression of the proapoptotic protein caspase 3, preventing cell apoptosis, and improving liver disease (26).